Acumen Pharmaceuticals, Inc. (ABOS) PT Lowered to $17 at Stifel
Tweet Send to a Friend
Stifel analyst Paul Matteis lowered the price target on Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) to $17.00 (from $27.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
